Page last updated: 2024-10-30

lansoprazole and Pulmonary Aspergillosis

lansoprazole has been researched along with Pulmonary Aspergillosis in 1 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Pulmonary Aspergillosis: Infections of the respiratory tract with fungi of the genus ASPERGILLUS.

Research Excerpts

ExcerptRelevanceReference
" After undergoing 1 year of voriconazole therapy for pulmonary aspergillosis, a 44-year-old man began treatment with 30 mg lansoprazole for gastroesophageal reflux symptoms."4.93Voriconazole-Induced Hepatitis via Simvastatin- and Lansoprazole-Mediated Drug Interactions: A Case Report and Review of the Literature. ( Lopez, JL; Tayek, JA, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lopez, JL1
Tayek, JA1

Reviews

1 review available for lansoprazole and Pulmonary Aspergillosis

ArticleYear
Voriconazole-Induced Hepatitis via Simvastatin- and Lansoprazole-Mediated Drug Interactions: A Case Report and Review of the Literature.
    Drug metabolism and disposition: the biological fate of chemicals, 2016, Volume: 44, Issue:1

    Topics: Adult; Antifungal Agents; Biotransformation; Chemical and Drug Induced Liver Injury; Cytochrome P-45

2016